{"id":790134,"date":"2023-10-12T18:58:43","date_gmt":"2023-10-12T22:58:43","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/xtant-medical-highlights-growing-product-portfolio-at-nass-2023\/"},"modified":"2023-10-12T18:58:43","modified_gmt":"2023-10-12T22:58:43","slug":"xtant-medical-highlights-growing-product-portfolio-at-nass-2023","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/xtant-medical-highlights-growing-product-portfolio-at-nass-2023\/","title":{"rendered":"Xtant Medical Highlights Growing Product Portfolio at NASS 2023"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">BELGRADE, Mont., Oct.  12, 2023  (GLOBE NEWSWIRE) &#8212; Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced it will exhibit its suite of orthobiologics and spinal fixation products at the North American Spine Society (NASS) 2023 Annual Meeting, which will be held October 18-21 at the Los Angeles Convention Center in Los Angeles, CA.<\/p>\n<p align=\"justify\">\u201cIn recent years, we have dramatically expanded our product portfolio, most notably with the introductions of the highly popular OsteoFactor and OsteoVive Plus products and the newly added Coflex and CoFix products,\u201d said Sean Browne, Chief Executive Officer of Xtant Medical. \u201cSpinal surgeons and physicians recognize the critical patient benefits from our complementary biologics and fixation product offerings. We are proud that Xtant remains at the forefront of innovative spinal solutions, and look forward to showcasing our deep portfolio at NASS.\u201d<\/p>\n<p align=\"justify\">Physicians, surgeons and members of the financial community interested in learning more about Xtant\u2019s products can visit Xtant\u2019s Booth #1603 or contact <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=35HHfBiGE-pqRRHAlRD70Nftsmv7ayh4MHTAXFVo6hKhQiQ7Bjaqk1s4aiDpyVEeJqCc9wFVdXNfGsZWCXM22akECkLqIrfl9VVIpREpATWSctgnVRBpMqO6X7JU0_ix\" rel=\"nofollow noopener\" target=\"_blank\">Marketing@xtantmedical.com<\/a>.<\/p>\n<p align=\"justify\">\n        <strong>About the North American Spine Society<\/strong>\n      <\/p>\n<p align=\"justify\">NASS a global multidisciplinary medical organization dedicated to fostering the highest quality, ethical, value-based and evidenced-based spine care by promoting education, research and advocacy. NASS is comprised of more than 8,000 members from several disciplines, including orthopedic surgery, neurosurgery, physiatry, neurology, radiology, anesthesiology, research and physical therapy. For more information, visit www.spine.org, NASS\u2019 Facebook, Twitter, Instagram and LinkedIn channels.<\/p>\n<p align=\"justify\">\n        <strong>About Xtant Medical Holdings, Inc.<\/strong>\n      <\/p>\n<p align=\"justify\">Xtant Medical Holdings, Inc. (www.xtantmedical.com) is a global medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Xtant people are dedicated and talented, operating with the highest integrity to serve our customers.<\/p>\n<p align=\"justify\">The symbols \u2122 and \u00ae denote trademarks and registered trademarks of Xtant Medical Holdings, Inc. or its affiliates, registered as indicated in the United States, and in other countries. All other trademarks and trade names referred to in this release are the property of their respective owners.<\/p>\n<p>\n        <strong>Investor Relations Contact<\/strong>\n      <\/p>\n<p>David Carey<br \/>FINN Partners<br \/>Ph: 212-867-1762<br \/>Email: david.carey@finnpartners.com<\/p>\n<p>      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODk0ODQ3MSM1ODcwNjg5IzIwMDYzNjE=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/ZDZlOGUzNTAtZTdmZC00YjNlLWJlNTUtOTBiMWRlNDEzY2JiLTEwMTc5MzQ=\/tiny\/Xtant-Medical-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>BELGRADE, Mont., Oct. 12, 2023 (GLOBE NEWSWIRE) &#8212; Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced it will exhibit its suite of orthobiologics and spinal fixation products at the North American Spine Society (NASS) 2023 Annual Meeting, which will be held October 18-21 at the Los Angeles Convention Center in Los Angeles, CA. \u201cIn recent years, we have dramatically expanded our product portfolio, most notably with the introductions of the highly popular OsteoFactor and OsteoVive Plus products and the newly added Coflex and CoFix products,\u201d said Sean Browne, Chief Executive Officer of Xtant Medical. \u201cSpinal surgeons and physicians recognize the critical patient benefits from &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/xtant-medical-highlights-growing-product-portfolio-at-nass-2023\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Xtant Medical Highlights Growing Product Portfolio at NASS 2023&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-790134","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Xtant Medical Highlights Growing Product Portfolio at NASS 2023 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/xtant-medical-highlights-growing-product-portfolio-at-nass-2023\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Xtant Medical Highlights Growing Product Portfolio at NASS 2023 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"BELGRADE, Mont., Oct. 12, 2023 (GLOBE NEWSWIRE) &#8212; Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced it will exhibit its suite of orthobiologics and spinal fixation products at the North American Spine Society (NASS) 2023 Annual Meeting, which will be held October 18-21 at the Los Angeles Convention Center in Los Angeles, CA. \u201cIn recent years, we have dramatically expanded our product portfolio, most notably with the introductions of the highly popular OsteoFactor and OsteoVive Plus products and the newly added Coflex and CoFix products,\u201d said Sean Browne, Chief Executive Officer of Xtant Medical. \u201cSpinal surgeons and physicians recognize the critical patient benefits from &hellip; Continue reading &quot;Xtant Medical Highlights Growing Product Portfolio at NASS 2023&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/xtant-medical-highlights-growing-product-portfolio-at-nass-2023\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-10-12T22:58:43+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODk0ODQ3MSM1ODcwNjg5IzIwMDYzNjE=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/xtant-medical-highlights-growing-product-portfolio-at-nass-2023\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/xtant-medical-highlights-growing-product-portfolio-at-nass-2023\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Xtant Medical Highlights Growing Product Portfolio at NASS 2023\",\"datePublished\":\"2023-10-12T22:58:43+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/xtant-medical-highlights-growing-product-portfolio-at-nass-2023\\\/\"},\"wordCount\":366,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/xtant-medical-highlights-growing-product-portfolio-at-nass-2023\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODk0ODQ3MSM1ODcwNjg5IzIwMDYzNjE=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/xtant-medical-highlights-growing-product-portfolio-at-nass-2023\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/xtant-medical-highlights-growing-product-portfolio-at-nass-2023\\\/\",\"name\":\"Xtant Medical Highlights Growing Product Portfolio at NASS 2023 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/xtant-medical-highlights-growing-product-portfolio-at-nass-2023\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/xtant-medical-highlights-growing-product-portfolio-at-nass-2023\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODk0ODQ3MSM1ODcwNjg5IzIwMDYzNjE=\",\"datePublished\":\"2023-10-12T22:58:43+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/xtant-medical-highlights-growing-product-portfolio-at-nass-2023\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/xtant-medical-highlights-growing-product-portfolio-at-nass-2023\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/xtant-medical-highlights-growing-product-portfolio-at-nass-2023\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODk0ODQ3MSM1ODcwNjg5IzIwMDYzNjE=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODk0ODQ3MSM1ODcwNjg5IzIwMDYzNjE=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/xtant-medical-highlights-growing-product-portfolio-at-nass-2023\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Xtant Medical Highlights Growing Product Portfolio at NASS 2023\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Xtant Medical Highlights Growing Product Portfolio at NASS 2023 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/xtant-medical-highlights-growing-product-portfolio-at-nass-2023\/","og_locale":"en_US","og_type":"article","og_title":"Xtant Medical Highlights Growing Product Portfolio at NASS 2023 - Market Newsdesk","og_description":"BELGRADE, Mont., Oct. 12, 2023 (GLOBE NEWSWIRE) &#8212; Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced it will exhibit its suite of orthobiologics and spinal fixation products at the North American Spine Society (NASS) 2023 Annual Meeting, which will be held October 18-21 at the Los Angeles Convention Center in Los Angeles, CA. \u201cIn recent years, we have dramatically expanded our product portfolio, most notably with the introductions of the highly popular OsteoFactor and OsteoVive Plus products and the newly added Coflex and CoFix products,\u201d said Sean Browne, Chief Executive Officer of Xtant Medical. \u201cSpinal surgeons and physicians recognize the critical patient benefits from &hellip; Continue reading \"Xtant Medical Highlights Growing Product Portfolio at NASS 2023\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/xtant-medical-highlights-growing-product-portfolio-at-nass-2023\/","og_site_name":"Market Newsdesk","article_published_time":"2023-10-12T22:58:43+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODk0ODQ3MSM1ODcwNjg5IzIwMDYzNjE=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/xtant-medical-highlights-growing-product-portfolio-at-nass-2023\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/xtant-medical-highlights-growing-product-portfolio-at-nass-2023\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Xtant Medical Highlights Growing Product Portfolio at NASS 2023","datePublished":"2023-10-12T22:58:43+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/xtant-medical-highlights-growing-product-portfolio-at-nass-2023\/"},"wordCount":366,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/xtant-medical-highlights-growing-product-portfolio-at-nass-2023\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODk0ODQ3MSM1ODcwNjg5IzIwMDYzNjE=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/xtant-medical-highlights-growing-product-portfolio-at-nass-2023\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/xtant-medical-highlights-growing-product-portfolio-at-nass-2023\/","name":"Xtant Medical Highlights Growing Product Portfolio at NASS 2023 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/xtant-medical-highlights-growing-product-portfolio-at-nass-2023\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/xtant-medical-highlights-growing-product-portfolio-at-nass-2023\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODk0ODQ3MSM1ODcwNjg5IzIwMDYzNjE=","datePublished":"2023-10-12T22:58:43+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/xtant-medical-highlights-growing-product-portfolio-at-nass-2023\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/xtant-medical-highlights-growing-product-portfolio-at-nass-2023\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/xtant-medical-highlights-growing-product-portfolio-at-nass-2023\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODk0ODQ3MSM1ODcwNjg5IzIwMDYzNjE=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODk0ODQ3MSM1ODcwNjg5IzIwMDYzNjE="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/xtant-medical-highlights-growing-product-portfolio-at-nass-2023\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Xtant Medical Highlights Growing Product Portfolio at NASS 2023"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/790134","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=790134"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/790134\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=790134"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=790134"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=790134"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}